CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Suppression of Colonic Polyposis by Homeoprotein CDX2 through its Nontranscriptional Function that Stabilizes p27Kip1

(2011) Koji Aoki et al.   CANCER RESEARCH

DNA Methylation Changes in Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, and Lung Adenocarcinoma

(2011) Suhaida A. Selamat et al.   PLoS One

SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma

(2010) Yan Jia et al.   Epigenetics

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

WNT Signaling in Lung Disease

(2009) Melanie Königshoff et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

The intestine-specific transcription factor Cdx2 inhibits β-catenin/TCF transcriptional activity by disrupting the β-catenin–TCF protein complex

(2009) Rong-Jun Guo et al.   CARCINOGENESIS

Pathogenesis of lung cancer signalling pathways: roadmap for therapies

(2009) E. Brambilla et al.   EUROPEAN RESPIRATORY JOURNAL

CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance

(2009) Do Youn Park et al.   MODERN PATHOLOGY

DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer

(2008) Malcolm V. Brock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epigenetics in Cancer

(2008) Manel Esteller   NEW ENGLAND JOURNAL OF MEDICINE

Wnt signaling pathway and lung disease

(2008) Michelle Van Scoyk et al.   Translational Research